Since 2015, the University at Buffalo has increased by more than 30 percent the funding it receives to conduct clinical trials, while the number of Western New Yorkers participating in UB clinical research has grown by two-thirds.
There are many ways members of the public can participate in research, from focus groups to patient advocacy groups to volunteering in a clinical study. Participants report feeling more satisified with their health care and can potentialy gain access to new treatments avaialble only to research volunteers.
“Tricks, Treats and Science Discoveries: Free Family Fun and Learning Fair” is returning to the Buffalo Niagara Medical Campus (BNMC) on Saturday, October 27, from 1 to 4 p.m. in the University at Buffalo Jacobs School of Medicine and Biomedical Sciences.
Since 2015, when the National Institutes of Health awarded UB the Clinical and Translational Science Award (CTSA), clinical trial research has significantly expanded. That expansion has brought with it a stronger emphasis on using new approaches, both high-tech and low-tech, to bring cutting-edge health care to more Western New Yorkers.
A comprehensive, university-wide effort to boost clinical research at UB is paying off. Since 2015, the university has increased by more than 30 percent the funding it receives to conduct clinical trials supported by both the federal government and private industry.
A paper published this summer in the Journal of Clinical and Translational Science marked the culmination of a two-year collaboration between four universities that’s being called a model of multi-site, team-based translational science.
The Primary Care Research Institute currently has an opening in its T32 National Research Service Award (NRSA) fellowship program. This T32 fellowship prepares primary care research (PCR) fellows (both health professional and research-related doctorates) with PCR skills, emphasizing the Triple Aim research agenda.
The Young Scientist Research Program is a two-week immersive summer school program conducted by the Biology Department at Canisius College for local high school students who may be considering science majors in college.
A five-year, $2.5 million grant awarded last summer to the Department of Biomedical Informatics in the Jacobs School of Medicine and Biomedical Sciences is helping to train a new generation of research leaders in the analysis and interpretation of complex health care datasets.
The prime point of entry for researchers seeking access to the services and resources provided by the University at Buffalo’s Clinical and Translational Science institute (CTSI) is the online Service Request Portal. On June 29, the CTSI unveiled its Service Request Portal version 2.0, which features significant upgrades on both the front end and back end.
New drugs and diagnostic tests go through years of clinical trials before being approved. But while regulatory approval is an enormous hurdle, getting through that process doesn’t automatically ensure that patients have access to these medical innovations.
A group of 66 undergraduate students who are participating in summer programs in the health sciences at UB came to the Clinical and Translational Research Center (CTRC) to learn all about careers in clinical and translational research from experts already working in the field.
The intrepid cyclists of the CTSI Research Riders took to the streets of Western New York to raise money for Roswell Park Comprehensive Cancer Center. The team of 11 CTSI employees, friends and family members raised $4,060.
The next series of Open Research Office sessions will provide principal investigators and research coordinators with an expert take on a crucial aspect of the scientific endeavor: planning and managing research budgets.
Faculty and staff members from UB’s Clinical and Translational Science Institute (CTSI) were among those recognized at a ceremony following the annual Stockton Kimball Lecture at the Jacobs School of Medicine and Biomedical Sciences on June 6.
Steven J. Fliesler, PhD, Meyer H. Riwchun Endowed Chair Professor, vice chair of ophthalmology and co-director of the CTSI Translational Pilot Studies Program, is one of four Jacobs School of Medicine and Biomedical Sciences faculty who have been appointed to the rank of SUNY Distinguished Professor.
A screening of the film "The Immortal Life of Henrietta Lacks" followed by a panel discussion was meant to build trust between clinical-translational researchers and members of the surrounding community.
A trio of clinical and translational research experts spoke at the March 26 Scientific Communications Core Competency Workshop, the fifth out of six workshops in the series offered by the CTSI’s Workforce Development core.
A renewed commitment to advancing research by UB and its partners on the Buffalo Niagara Medical Campus has led to an increase in the number of local clinical studies, giving more Western New York patients the benefit of cutting-edge treatments that have significantly improved their lives.
“Enhancing Workforce Excellence and Cultural Diversity by Broadening Participation and Professional Development” will present approaches to increasing diversity and enhancing excellence in both educational programs and the translational research workforce.
The University at Buffalo’s Clinical and Translational Science Institute (CTSI), with local institutional support and an award from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, has awarded 11 new grants to support promising translational research projects in Western New York.
Nikhil Satchidanand, PhD, one of the first KL2 Scholars in the University at Buffalo Clinical and Translational Science Award-linked KL2 Mentored Career Development Award (MCDA) program, has joined the faculty of the Jacobs School of Medicine and Biomedical Sciences Department of Medicine as an assistant professor, it was announced in February.
This month UB’s Clinical and Translational Science Institute (CTSI) welcomed two new scholars to the ranks of the Buffalo Translational Consortium (BTC) Mentored Career Development Award (MCDA) program.
Two publications in prestigious, peer-reviewed journals which explore treatments for substance use disorders were selected as winners of the Buffalo Translational Consortium 2017 Clinical Research Achievement Awards.
The CTSI Statistical Workshop Series, which began in September and continues through May, includes the following core competencies: statistical approaches, study design, sources of error, research questions and literature critique.
Margarita L. Dubocovich, PhD, director of the UB CTSI Workforce Development core and the program lead and principle investigator of the CTSI’s KL2 program, has been awarded the inaugural Dolores Shockley Minority Mentoring Award from the American College of Neuropsychopharmacology (ACNP).
If you’ve ever visited the fifth-floor atrium of the Clinical and Translational Research Center (CTRC), odds are you’ve noticed a large pine tree growing in the corner over by the north-facing windows.
The CTSI Workforce Development Core, Community Engagement Core and the KL2 Mentored Career Development Program are pleased to announce the Clinical and Translational Research Core Competencies on Community Engagement.
Starting January 25, 2018, NIH-defined clinical trial applications must be submitted using a Funding Opportunity Announcement (FOA) that is worded specifically for clinical trials. In the past, clinical trial applications could be submitted for FOAs that were not identified as being clinical-trial specific. Submitting to the wrong FOA will lead to rejection of your application.
An enthusiastic crowd of at least 175 local trick-or-treaters and their families turned out for the first-ever “Tricks, Treats and Discoveries: Family Fun and Learning Fair,” held October 28 in the Educational Opportunity Center on the Buffalo Niagara Medical Campus (BNMC).
The UB Clinical Research Office announced that effective Monday, November 13, 2017, two new initiatives to facilitate and support clinical research across UB will be initiated: Central Study Registration (CSR) and Department/School Scientific Review.
One of the main goals of UB’s Clinical and Translational Science Institute (CTSI) is to advance clinical and translational research that will improve the health and well-being of people living in Western New York, with a special emphasis on reducing the health disparities experienced by many in our community, including underrepresented minority groups and the poor.
James Marks, MD, MPH, a 1973 graduate of UB’s medical school and executive vice president at the Princeton-based Robert Wood Johnson Foundation, returned home during Alumni Weekend in October to talk about the economic impact that academic medical centers can have on a city like Buffalo.
An important goal of UB’s Clinical and Translational Science Institute (CTSI) is to improve the representativeness of research studies, including participants from special populations such as children, the elderly, underrepresented racial and ethnic groups, and people with disabilities.
The Fall Seminar Series at the University at Buffalo Research Institute on Addictions will feature national experts on heavy drinking in young adults, dating violence, financing addiction treatment and tobacco use.
An article in Health about a report from the Los Angeles coroner’s office that found that actress Carrie Fisher had multiple drugs in her system when she died after suffering a heart attack in December. The story features an extensive interview with Kenneth Leonard, who is the director of UB’s Research Institute on Addictions and a CTSI board member.
UB’s ongoing efforts to recruit underrepresented students in science, technology, engineering and mathematics (STEM) to its PhD programs have received a major boost from the National Institutes of Health, which renewed a five-year, $2.3 million grant to help fully fund scholarships.
BUFFALO, N.Y. – Rina Das Eiden, PhD, senior research scientist in the University at Buffalo’s Research Institute on Addictions, and a Buffalo Translational Consortium partner, has been named chair of the Psychosocial Development, Risk and Prevention Study Section in the National Institute of Health’s Center for Scientific Review.
L. Nelson “Nick” Hopkins is a pioneer in the use of catheters — long, flexible tubes — inserted into the vascular system in the groin and threaded to the brain to treat strokes. The procedure, once called “crazy” by the medical establishment, is now the preferred method in many situations.
Margarita L. Dubocovich, PhD, SUNY Distinguished Professor of pharmacology and toxicology has been awarded the UB President’s Medal, which recognizes “truly extraordinary effort on behalf the university and the communities we serve,” according to University at Buffalo President Satish K. Tripathi, PhD.
A National Institutes of Health (NIH) training grant aimed at providing professional development resources and mentoring for doctoral students in several UB schools has been renewed for another five years.
More than 20 UB faculty and staff members were on hand to represent the Clinical and Translational Science Institute (CTSI) at the Translational Science 2017 conference held in Washington, D.C., April 19-21.
The University at Buffalo Jacobs School of Medicine and Biomedical Sciences welcomed a scientific celebrity to campus for the Clinical and Translational Science Institute (CTSI) Seminar Series/O.P. Jones Lecture on May 2.
Four Western New York medical practitioners were honored on April 28 by the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, including two faculty members associated with the UB Clinical and Translational Science Institute (CTSI).
The University at Buffalo Clinical and Translational Science Institute (CTSI) Science Seminar Series is pleased to present renowned biophysicist and professor of structural biology Michael Levitt for the 2017 O.P. Jones Lecture entitled, “The Birth and Future of Multiscale Modeling of Macromolecules.”
The theme of the University at Buffalo School of Nursing 2017 Research Day, held on March 31, was opioid addiction treatment and prevention, a public health problem that continues to plague Western New York and many communities throughout the nation.
The main objective of the University at Buffalo Clinical and Translational Science Institute (CTSI) Drug Development Core is to foster innovation in drug development and clinical therapeutics research.
An illustrious researcher in the field of infectious disease epidemiology was the guest speaker at the inaugural Clinical and Translational Science Institute 2017 Seminar Series on Feb. 10 in Farber Hall on UB’s South Campus. A standing-room-only crowd in the 105-seat lecture hall welcomed Arnold S. Monto, MD, to town for the seminar, co-sponsored by the UB School of Public Health and Health Professions and the CTSI.
Reproducible research, in which statistical programming and documentation is sufficient so that others may replicate results and the research process, is gaining widespread practice in biostatistics and many other areas of science.